Clinical Trials and the Insurance Implications

Decentralised and Adaptive Clinical Trials

In the second episode of our Clinical Trials Podcast Series, Jenny Yu, Chemical and Life Sciences Industry Practice Leader, Marsh UK, is joined by Joe Shaw from Marsh’s Clinical Trials Centre of Excellence and Ben Ward from Newline Insurance, to discuss the subject of decentralised and adaptive trials, the increasing use of technology, and how these impact the risks and insurance.

Clinical Trials and the Insurance Implications

The subject of clinical trials, and their insurance is a key for the life sciences sectors, as the testing and approval of treatments is a vital stage in the process of getting those treatments to the people that need them.  In our recent podcast, Chemical and Life Sciences Industry Leader, Jenny Yu, hosts a discussion with Joe Shaw and Paddy Collins from Marsh’s Clinical Trials Centre of Excellence and Ben Ward from Newline Insurance, covering recent developments in clinical trials, the impacts of global pressures and the insurance implications. For more insights and insurance and risk management solutions, follow Marsh on LinkedIn and Twitter and visit marsh.com.